Ex vivo excimer laser ablation of cornea guttata and ROCK inhibitor-aided endothelial recolonization of ablated central cornea.
Stefan KassumehAnnabel von StudnitzSiegfried G PriglingerRudolf FuchshoferNikolaus LuftGregory MoloneyMartin DirisamerAndreas OhlmannPublished in: Acta ophthalmologica (2020)
Our proof of concept study demonstrated that excimer lasers can be used to ablate diseased tissue from excised FECD Descemet membranes ex vivo. Additionally, corneal endothelial cells recolonize a previously ablated endothelial area in healthy human corneas ex vivo under treatment with ripasudil. Thus, our results are the first experimental basis to further investigate the feasibility of an excimer laser ablation as a graftless FECD treatment option.